GlassScriptPhysician profile
John H Sirak
NPI 1568418622
$7,693.02
in general payments reported to CMS, 2019-2025
26 companies · $503 in 2025
The $503 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,199 · 2020: $285 · 2021: $765 · 2022: $2,848 · 2023: $693 · 2024: $400 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,191 · Travel and Lodging: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,191.15 |
| Travel and Lodging | $404.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,017.98 | 2019-2024 | Epic, Navitor, Cardiomems |
| Medtronic, INC. | $2,676.29 | 2021-2025 | Vitalflow Console, Avalus |
| Edwards Lifesciences Corporation | $433.21 | 2019-2025 | Evoque |
| Atricure, INC. | $293.54 | 2019-2023 | |
| Clearflow INC. | $223.41 | 2019 | |
| Abiomed | $205.12 | 2021 | |
| Medtronic Vascular, INC. | $189.50 | 2019-2020 | |
| Endologix LLC | $119.88 | 2019 | |
| Novartis Pharmaceuticals Corporation | $76.13 | 2023 | |
| Lsi Solutions INC | $53.52 | 2019-2020 | |
| Davol INC. | $50.23 | 2019-2023 | Progel Applicator Spray Tips |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.71 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $45.70 | 2019-2021 | |
| Pfizer INC. | $32.75 | 2022-2023 | |
| Astellas Pharma US INC | $27.84 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $25.68 | 2019-2020 | |
| Cvrx, INC. | $25.36 | 2024 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $25.06 | 2020-2021 | |
| Bracco Diagnostics INC. | $19.83 | 2025 | |
| Kci USA, INC. | $17.59 | 2020 | |
| Covidien LP | $17.27 | 2019 | |
| Livanova USA, INC. | $16.79 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.69 | 2021 | |
| Boston Scientific Corporation | $14.05 | 2025 | Cds - Mct/Cem Monitoring |
| Avanos Medical | $12.59 | 2019 | |
| Amgen INC. | $11.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sirak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.